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Regulation of Endothelial Cell and Endothelial Progenitor
Cell Survival and Vasculogenesis by Integrin-Linked Kinase
Hyun-Jai Cho, Seock-Won Youn, Soo-In Cheon, Tae-Youn Kim, Jin Hur, Shu-Ying Zhang,
Seung Pyo Lee, Kyung-Woo Park, Myoung-Mook Lee, Yun-Shik Choi,
Young-Bae Park, Hyo-Soo Kim
Objective—New vessel formation is a dynamic process of attachment, detachment, and reattachment of endothelial cells
(ECs) and endothelial progenitor cells (EPCs) with each other and with the extracellular matrix (ECM). Integrin-linked
kinase (ILK) plays a pivotal role in ECM-mediated signaling. Therefore, we investigated the role of ILK in ECs and
EPCs during neovascularization.
Methods and Results—In human umbilical cord vein ECs and EPCs, endogenous ILK expression, along with subsequent
cell survival signals phospho-Akt and phospho–glycogen synthase kinase 3, was reduced after anchorage or nutrient
deprivation. Even brief anchorage deprivation resulted in retarded capillary tube formation by ECs. Adenoviral ILK
gene transfer in ECs and EPCs reversed the decrease in cell survival signals after anchorage or nutrient deprivation,
leading to enhanced survival, reduced apoptosis, and significantly accelerated the functional recovery after reattachment.
And ILK overexpressing EPCs significantly improved blood flow recovery and prevented limb loss in nude mice
hindlimb ischemia model. Furthermore, the efficacy of systemic delivery was equivalent to local injection of ILK-EPCs.
Conclusions—ILK overexpression protects ECs and EPCs from anchorage- or nutrient-deprived stress and enhances
neovascularization, suggesting that ILK is an optimal target gene for genetically modified cell-based therapy.
Neovascularization is a dynamic process of detachment and reattachment of ECs and EPCs. Endogenous ILK expression
was decreased in various stress conditions, and the gene transfer of ILK protected ECs and EPCs from temporary
anchorage or nutrient deprivation. Furthermore, ILK gene transfer in EPCs significantly enhanced neovascularization in
vivo. (Arterioscler Thromb Vasc Biol. 2005;25:1154-1160.)
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New vessel formation or angiogenesis is a complexprocess1,2 that may be simplified as a sequential process
of endothelial cell (EC) detachment from the extracellular
matrix (ECM), reattachment onto new ECM, and final incor-
poration into new vasculature. The ability of ECs to form
capillary-like structures is essential for angiogenesis in vivo.
However, in ischemic tissue, because of the disruption of the
microenvironment, which is necessary for sprouting and
recruiting of pre-existing ECs, the survival and incorporation
of ECs are not facilitated.3
There is accumulating evidence that endothelial progenitor
cells (EPCs) contribute to vessel growth in ischemic and
inflamed tissue in adults.4–6 Despite its promising application
for tissue regeneration, the limited endogenous pool and the
possible functional impairment associated with a variety of
physiological and pathological conditions limit its use on
clinical patients.7 Various types of genetic modifications of
EPCs are under investigation to overcome such limitations.8,9
Most of the studies focused on the survival and proliferation
of EPCs, and few studies, if any, focused on the overall
vasculogenic sequence of EPCs, which are usually mobilized
or injected at a remote site from target tissue in the
anchorage-deprived detached status, and finally reattach and
incorporate into the ischemic target area.
The dynamic interactions between cell–ECM and cell–cell
play critical roles during angiogenesis.10 Cell adhesion to the
ECM results in differentiation, proliferation, and suppression
of apoptosis.11 Integrin-linked kinase (ILK) is a novel,
ankyrin repeat–containing serine threonine kinase that exhib-
its cell type-dependent activation and inhibition,12 the activity
of which is rapidly and transiently stimulated by cell–ECM
interaction.13 It is an important regulator of cell–ECM inter-
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action that leads to cell survival and death.14 However, the
function of this gene on ECs and EPCs during the angiogenic
process is largely unknown.
Therefore, we investigated the basal expression pattern of
ILK in ECs and EPCs in various stress conditions, such as
detachment (anchorage deprivation), reattachment, and nutri-
ent deprivation, and examined the effects of ILK gene
transfer on survival, apoptosis, and capillary formation in
vitro, along with the downstream signaling pathway of ILK
that controls the survival and apoptosis of EPCs. Moreover,
the effects of ILK-modified EPCs on neovascularization in
vivo, was also studied in a hindlimb ischemia model.
Methods
Cell Culture
Human umbilical vein ECs (HUVECs; Cambrex) were plated on 2%
gelatin-coated (Sigma) dishes and cultured in EC basal medium
(EBM) or EC growth medium (EGM; Clonetics) supplemented with
5% FBS.
For EPC cultures, 50 cc of peripheral blood was obtained from
healthy volunteers with informed consent. The mononuclear cells
were fractionated as described previously.15,16 Isolated mononuclear
cells were resuspended by EGM–2MV media with 5% FBS. Cells
were plated on gelatin-coated plates with 2106 cells/cm2 density.
Three-week cultured cobblestone-shaped EPCs were used as we
reported previously.16,17 All experiments dealing with humans or
human products were approved by the institutional review board of
Seoul National University Hospital.
To examine the kinetics of ILK expression on suspension culture,
HUVECs and EPCs were trypsinized and seeded on the poly-
hydroxyethylmethacrylate (poly-HEMA)– coated dishes. Poly-
HEMA solution (10 mg/mL; Sigma), an adhesion inhibitor, was
dispensed to cover the entire surface of each well or dish as described
previously.18 After suspension on poly-HEMA– coated dishes,
HUVECs and EPCs were cultured on gelatin-coated dishes to
evaluate the reattachment and growth of the transiently anchorage-
deprived cells. Cells were also cultured in EBM with no FBS
supplemented for the nutrient-deprived condition.
Recombinant ILK Adenovirus
Construction of adenovirus ILK (Ad-ILK), human wild-type ILK
plasmid (Upstate), was cloned into a shuttle vector (pAdTrack-
CMV). The recombinant shuttle vector was cotransfected with
adenoviral genome (pAdEasy-1)–containing green fluorescence pro-
tein (GFP) gene also into Escherichia coli (BJ5183), where homol-
ogous recombination occurred. The construct of Ad-ILK was con-
firmed by DNA sequencing, and the expression was confirmed by
immunoblot analysis. Adenovirus-encoding GFP was used as control
viral transduction.
Western Blotting, Cell Viability Assays, and
Apoptosis Analysis
Immunoblot assays were performed by modification of the proce-
dures described previously.19 The membrane was incubated with
primary antibody, ILK (Cell Signaling), phospho-AKT (S473; Cell
Signaling), and phospho–glycogen synthase kinase-3 (GSK3; S9;
Cell Signaling), overnight at 4°C. Enhanced chemiluminescence
(ECL) or ECL-PLUS (Amersham) was used for detection.
Cell viability was assessed by cell proliferation reagent WST-1
assay, as instructed by the manufacturer (Roche), and apoptosis was
measured by fluorescence-activated cell sorting (fluorescence-acti-
vated cell sorter [FACS]) of hypodiploid DNA, and observations of
pyknotic nuclei and phosphatidylinositol staining by modification of
procedures described previously.19,20
In Vitro Capillary Formation
Matrigel (Becton Dickinson Labware) basement membrane matrix
was thawed and mixed 1:1 with EBM. Diluted Matrigel was added
to chamber slide. After 1 hour incubation at room temperature,
2104 cells were added to the chamber slide with 500 L EGM. The
slide was observed under an inverted microscopy 12 hours later. Five
representative fields were taken, and the average of the total area of
tubes completely formed by cells or the total length of the tubes was
compared.
In Vitro Incorporation
Twenty-four hours after gene transfer, Ad-ILK EPCs and Ad-GFP
EPCs were incubated on a monolayer of HUVECs. Five hours after
incubation, nonadherent cells were removed by washing with PBS.
The total number of adhesive EPCs in each well was counted under
a 100 magnification field of a fluorescent microscope.8
In Vivo Transplantation of Genetically Modified
EPCs in Hindlimb Ischemia Model
Female athymic nude mice (n41; Daehan Biolink; Korea) 7 to 8
weeks old weighing 17 to 20 g were anesthetized, and an ipsilateral
femoral artery was surgically removed as described previously.21
EPCs transduced with Ad-ILK or Ad-GFP were washed gently 5
with PBS, harvested by brief trypsinization, and resuspended with
growth factor–free EBM. The suspension volume of injected cells
was 100 L. On the basis of our previously reported laboratory
data,16,17 the dose of injected cells was determined to be from 1104
to 2105 per mouse because too high of a dose of EPCs may salvage
most limbs and conceal the effect of Ad-ILK on angiogenic potential
of EPCs. As an administrative route for EPCs, we chose direct cell
infusion into systemic arterial circulation through left ventricular
cavity to determine the tolerance of EPC anchorage-deprived stress
during angiogenesis or direct local muscular injection into 4 separate
sites of thigh muscle to minimize cellular stress. All animal exper-
iments were performed after receiving approval of the Institutional
Animal Care and Use Committee of Clinical Research Institute in
Seoul National University Hospital and complied with National
Research Council Guidelines for the Care and Use of Laboratory
Animals (revised 1996).
Physiological and Histological Evaluation of In
Vivo Angiogenesis Effect
Each mouse was followed by serial recording of surface blood flow
of hindlimb on days 0, 3, 7, 14, and 21 by laser Doppler perfusion
imager (Moor Instrument). Photos of limb were also recorded and
visually analyzed as “limb salvage” (completely normal status
without a sign of ischemia), “foot necrosis” (necrosis of toe or below
knee), or “auto amputation” (necrosis or loss of tissue above knee).
Tissue vascular density was determined at the microvascular level
as a histological evaluation of neovascularization. At day 21, mice
were euthanized, and the lower thigh muscles of ischemic limb were
harvested and snap-frozen in liquid nitrogen–chilled isopentane.
Tissues were embedded in OCT compound (Sakura Finetek), and
multiple 10-m-thick slices were prepared. Tissue sections were
stained with tetramethylrhodamine B isothiocyanate (TRITC)–con-
jugated murine EC–specific Bandeiraea simplicifolia lectin 1 (BS-1;
Sigma). Five random fields were selected from each slice, and
fluorescent vascular ECs were counted.
Statistical Analysis
All data are presented as the meanSEM. Statistical significance
was evaluated by means of Student’s t test or ANOVA with
Bonferroni’s correction using SPSS version 11.0. The incidence of
limb salvage was evaluated by 2 test. A P value of 0.05 was
considered to denote statistical significance.
Results
Expression of Endogenous ILK in ECs and EPCs
Decreased in Various Stresses
Western blot analysis was used to characterize the endoge-
nous expression of ILK in HUVECs under various stressful
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conditions such as detachment (anchorage deprivation), reat-
tachment, and nutrient deprivation (Figure 1). Endogenous
ILK expression in ECs was transiently upregulated during 6
hours after detachment, and then it was decreased rapidly.
However, on reattachment on ECM after detachment, the
expression of ILK recovered. Next, we compared ILK ex-
pression patterns between HUVECs and EPCs by serial
immunoblot analysis (Figure 1) and reconfirmed by paired
immunoblot (Figure IA, available online at http://atvb.
ahajournals.org). Overall, the serial ILK expression pattern of
EPCs was similar to HUVECs. However, in EPCs, the basal
level of endogenous ILK was upregulated, peaking at 6 hours
of anchorage deprivation as cultured on poly-HEMA (adhe-
sion inhibitor)–coated dish, and then decreased much more
slowly than HUVECs (Figure IB). After 48 hours of detached
stress, EPCs were reattached on gelatin-coated dish, which
led to increased expression of ILK and its downstream
molecules phosphorylated forms of Akt and GSK3, lasting
for 24 hours. In the nutrient deprivation (serum-free and
growth factor–free media), ILK expression rapidly decreased
in HUVECs, whereas it was maintained and decreased slowly
in EPCs.
ILK Protects HUVECs From Apoptosis by
Anchorage Deprivation and Promotes Cell
Proliferation and Tube Formation
After Reattachment
Adenovirus encoding the human ILK gene followed by GFP
gene under the control of a CMV promoter (Ad-ILK) was
constructed to investigate the effects of ILK overexpression.
The survival, apoptosis of HUVECs, and the expression of
downstream molecules of ILK were examined 48 hours after
anchorage deprivation in cells transfected with Ad-ILK.
Survival of HUVECs transfected with Ad-ILK increased
significantly by 2-fold (P value 0.01) compared with
Ad-GFP HUVECs (Figure 2A) as measured by WST-1 assay.
In addition, ILK gene transfer protected HUVECs from
detachment-induced apoptosis (apoptotic fraction 41% versus
63% for Ad-ILK versus Ad-GFP HUVECs) as measured by
FACS analysis. Accordingly, the expression of downstream
Figure 1. ILK expression in various
stressful conditions in ECs and EPCs.
Serial immunoblot analysis was used to
characterize the endogenous expression
level of the ILK in HUVECs and EPCs
exposed to various stresses such as
anchorage deprivation, reattachment,
and nutrient deprivation. Although the
overall expression pattern was similar
between the 2 cell types, the expression
of ILK was greater at baseline in EPCs
compared with mature ECs, and
decreased to a lesser degree after expo-
sure to various stresses.
Figure 2. Effects of ILK overexpression
in anchorage deprivation, reattachment,
and nutrient deprivation. A, After 15
hours of transfection, HUVECs were cul-
tured in EGM with 10% serum supple-
mented on poly-HEMA (adhesion inhibi-
tor)–coated dishes as anchorage-
deprived condition for 48 hours. The
impacts of ILK overexpression on cell
survival were confirmed by WST-1 assay.
*P0.01 vs GFP overexpressing
HUVECs. B, ILK gene transfer signifi-
cantly reversed the decline of survival
signals observed in the control cells with
GFP. C through E, Proliferation or capil-
lary formation of ECs, after reattachment,
was significantly retarded even after brief
anchorage deprivation. However, ILK
gene transfer significantly accelerated
the recovery of proliferation and function.
Cell proliferation was enhanced in ILK-
HUVECs after reattachment occurred (C).
Quantitative assay of proliferation
showed significant difference between
ILK-HUVECs and GFP-HUVECs (*P0.05; D). After anchorage deprivation, 2104 HUVECs were seeded on Matrigel-coated plates and
incubated for 12 hours. Quantitative tube length was significantly longer in ILK-HUVECs compared with GFP-HUVECs (*P0.01; E). F,
After 24 hours of nutrient deprivation, cell viability assay (WST-1) showed that ILK-HUVECs were twice as viable as GFP-HUVECs
(*P0.01). G and H, Tube formation was much more effective in ILK-HUVECs than GFP-HUVECs in the nutrient-deprived condition. In
quantitative analysis of tube formation, not only the tube length, but also the tube area with completely encircled HUVECs, was higher
in ILK-HUVECs than GFP-HUVECs. (*P0.05; H).
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molecules, active phospho-Akt, a well-known survival signal,
and inactive phospho-GSK3, a well known antiapoptotic
signal, were considerably increased in Ad-ILK HUVECs
compared with Ad-GFP HUVECs (Figure 2B).
After 24 hours of anchorage deprivation, HUVECs were
allowed to reattach on gelatin-coated dishes. After reattach-
ment, cell proliferation significantly increased in Ad-ILK
HUVECs compared with Ad-GFP HUVECs (Figure 2C and
2D), which led to functional improvement as measured by in
vitro Matrigel tube formation assay (Figure 2E), suggesting
that overexpression of ILK mediates recovery of cell prolif-
eration and function after reattachment.
ILK Protects HUVECs From Nutrient Deprivation
To demonstrate the effect of ILK gene transfer under nutrient
deprivation, HUVECs were starved serum and growth factor
in EBM for 24 hours. The viability of Ad-ILK HUVECs,
measured by WST-1 assay, was twice that of Ad-GFP
HUVECs (Figure 2F; P value 0.01), and the apoptotic
fraction was significantly reduced in the Ad-ILK HUVECs
(50% versus 65% for Ad-ILK versus Ad-GFP HUVECs).
Along with increased survival and resistance to apoptosis,
Ad-ILK HUVECs again showed significantly greater tube-
forming capacity compared with the Ad-GFP HUVECs in the
nutrient-deprived condition. Not only the network length of
the tubes, but also the tube area of capillaries completely
encircled with HUVECs was significantly greater in Ad-ILK
HUVECs (Figure 2G and 2H).
Impact of ILK Gene Transfer in EPCs
We then investigated the possibility of genetic modification
of EPCs with wild-type ILK. After full transduction with
either wild-type ILK or GFP, downstream molecule expres-
sion was similar to HUVECs overexpressing ILK or GFP
(Figure 3A). To confirm the functional improvement of
ILK-modified EPCs, in vitro incorporation of EPCs on
HUVEC monolayer was tested. Significantly more Ad-ILK
EPCs incorporated on the HUVEC monolayer compared with
Ad-GFP EPCs (Figure 3B and 3C). Under the anchorage- or
nutrient-deprived condition, EPCs overexpressing ILK
showed improved cell viability and reduced apoptosis com-
pared with Ad-GFP EPCs, similar to what was observed in
HUVECs (Figure 3D through 3G).
Genetically Modified EPCs Enhance Angiogenesis
In Vivo
In an athymic mouse hindlimb ischemia model, we tested the
systemic and local injection methods to assess the impact of
ILK transfection in vivo. One day after unilateral femoral
artery excision, athymic mice received either systemic (via
intracardiac injection) or local injections (via direct muscular
injection) of Ad-ILK EPCs or Ad-GFP EPCs (as control).
To determine the tolerance of anchorage deprivation and
reattachment stress, we performed systemic arterial delivery
and, to minimized anchorage-deprivation, direct local deliv-
ery was performed. We observed capillary density, serial
tissue perfusion, and fate of ischemic limb. In the histological
examination of skeletal muscle sections at day 21, capillary
density observed in the mice transplanted with ILK-EPCs
was significantly higher than in the mice with GFP-EPCs
(Figure 4); a similar result was observed in serial tissue
perfusion by laser Doppler images (Figure 5). More than half
of the mice that received systemic injection of 2105 GFP
EPCs (n6 of 11) developed extensive necrosis of the
ischemic hindlimb, and eventually, the limbs were auto
amputated during serial examination (Figure 5C). This find-
ing meant that systemic delivery of 2105 native EPCs was
insufficient for neovascularization in the athymic nude
mouse, which has inherent impaired angiogenesis. However,
when EPCs genetically modified by ILK transfection were
systemically injected, even at the 20 less dose (ILK4;
1104 ILK-EPCs), it resulted in a significantly better out-
come than the systemic delivery of GFP-EPCs (ILK4 versus
GFP, P0.01, Figure 4, capillary density; ILK4 versus GFP,
Figure 3. ILK overexpression in EPCs in
vitro. ILK gene transfer improved the in
vitro survival and function of EPCs. A,
Adenoviral transduction was performed
and confirmed with inverted fluorescence
microscope in ex vivo expanded human
EPCs. The upregulated expressions of
ILK and its downstream molecules were
confirmed by Western blots. B, In vitro
incorporation of ILK overexpressing
EPCs on HUVEC monolayer. More ILK-
EPCs incorporated into the HUVEC
monolayer compared with GFP-EPCs.
Green dots represent the incorporated
EPCs. C, Quantitative analysis of EPC
incorporation observed at 4 hours of
incubation (*P0.01). D and E, At 48
hours after anchorage deprivation, ILK-
EPCs were about twice as viable as
GFP-EPCs in WST-1 assay (*P0.05;
n6). The effect of ILK gene transfer to
reduce apoptosis by anchorage depriva-
tion was less dramatic in EPCs in FACS
analysis, which may be associated with
the high basal resistance of EPCs
against apoptosis by anchorage deprivation. F and G, Twenty-four hours after nutrient deprivation, ILK-EPCs were much more viable
than GFP-EPCs (*P0.01; n6). ILK overexpression also reduced EPCs apoptosis by 28% as measured by FACS analysis.
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P0.05, Figure 5B, tissue perfusion; ILK4 versus GFP,
P0.05, Figure 5C, final limb fate)
In the comparison between systemic and local delivery of
ILK-modified EPCs in the ischemic limbs, capillary density
in the local delivery group was greater than in the systemic
injection group (Figure 4; ILK5L versus ILK5; P0.02), but
recovery of tissue perfusion and final outcome was quite
comparable between 2 groups (Figure 5C). Between 2 differ-
ent cell dose (2105 and 1104), systemically delivered
ILK-EPCs groups, there was no significant difference in
capillary density, tissue perfusion, and final outcome.
Discussion
This study reveals that ILK is important in EC and EPC
biology, playing a pivotal role to control the cell survival,
proliferation, and apoptosis leading to modulation of capillary
tube formation in stressful conditions unavoidable during the
process of angiogenesis, such as anchorage or nutrient depri-
vation. Furthermore, we show that EPCs genetically modified
by ILK get the satisfactory outcome to salvage the ischemic
limb. Our data show for the first time the potential of ILK as
a target to improve the efficacy of cell-based therapeutic
angiogenesis.
Cell attachment is mediated mainly through the engage-
ment of ECM with integrin molecules.22 It has been shown
recently that the protein kinase signaling pathways control
anchorage-dependent cell survival positively and negative-
ly.23 ILK was first identified as a protein that binds to the
cytoplasmic domain of the 1-integrin subunit, and ILK
expression has been documented in the cardiac muscle,
skeletal muscle, kidney, and pancreas.12 Integrin-mediated
cell anchorage is essential for cell survival. It has been
demonstrated in epithelial cells and tumor cells that overex-
pression of ILK results in the stimulation of anchorage-
independent cell growth, cell cycle progression, and sup-
presses apoptosis.10,24,25 In ECs, it has been shown that
Figure 4. Histological analysis of trans-
planted animals. Administration of genet-
ically modified EPCs increased capillary
density in ischemic tissue. A, Represen-
tative merged histological images of en-
dothelial nuclei (red) and phase-contrast
(black and gray). Histological skeletal
muscle section retrieved from ischemic
hindlimb at 21 days was stained with
mouse EC–specific TRITC-conjugated
BS-1 lectin (n10; each group). B, In
quantitative analysis, ILK-EPCs
increased capillary density compared
with GFP-EPCs. Among ILK-EPCs
groups, local delivery group showed
greater capillary density than systemic
injection group. *P0.01, ILK4 (56765
/mm2), ILK5 (69574 /mm2), and ILK5L
(97577 /mm2) vs GFP (29330 /mm2);
#P0.3, ILK4 vs ILK5; †P0.02, ILK5 vs
ILK5L (GFP2105 GFP-EPCs delivered
systemically; ILK41104 ILK-EPCs
delivered systemically; ILK52105 ILK-
EPCs delivered systemically;
ILK5L2105 ILK-EPCs injected locally).
Figure 5. Therapeutic efficacy of ILK-
modified EPCs. In an athymic mouse
hindlimb ischemia model, EPCs geneti-
cally modified with ILK showed greater
efficacy to improve perfusion and
reduced limb loss. A, Efficacy of sys-
temic administration via intracardiac
delivery of 2105 GFP-EPCs as control
(n11) and 2105 of ILK-EPCs (n10),
and local administration of 2105 ILK-
EPCs by 4 injections into thigh muscle
(n10), were evaluated by laser Doppler
perfusion image analyzer. In these color-
coded images, white hue indicates
regions with maximum perfusion,
whereas blue represents lowest perfu-
sion area. B, To account for variations
among mice, perfusion is expressed as
the ratio of ischemic vs nonischemic
limbs. *P0.05, ILK4 vs GFP; #P0.05,
ILK5 vs GFP; †P0.01, ILK5L vs GFP. C,
Percent distribution shows the final out-
come of mice receiving GFP-EPC and ILK-EPCs, which were administered systemically or locally. *P0.01, ILK5L vs GFP; #P0.05,
ILK5 vs GFP; †P0.05, ILK4 vs GFP.
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oxidized low-density lipoprotein (LDL) induces ILK expres-
sion, and that overexpression of ILK can prevent oxidized
LDL–induced apoptosis.26
The endogenous ILK expression pattern, in response to
various stresses observed in our study, revealed that it is only
transiently upregulated and then decreased rapidly in ECs and
EPCs, which is insufficient to maintain cell survival and
proliferation in these stressful conditions. Although overall
ILK expression pattern in EPCs was similar to ECs, the
expression of ILK in EPCs was higher at baseline and
decreased more slowly than ECs after exposure to stressful
conditions, suggesting that the higher basal expression and
maintenance of such expression levels of ILK may play an
important role in opposing stresses. Taking this into account,
we examined the effect of ILK gene transfer in ECs and EPCs
under various stresses. The effects of ILK overexpression on
viability and apoptosis of EPCs in anchorage or nutrient
deprivation condition were somewhat different from those of
HUVECs. Under either anchorage-deprived or nutrient-
deprived stress, ILK gene transfer significantly increased the
viable cell numbers of EPCs as well as HUVECs. Regarding
the apoptosis, ILK gene transfer significantly reduced apo-
ptosis of EPCs and HUVECs in nutrient-deprived stress. But
in anchorage-deprived condition, antiapoptotic effect of ILK
gene transfer was less dramatic in EPCs than HUVECs; ILK
gene transfer reduced apoptosis of EPCs from 48% to 42%
and that of HUVECs from 63% to 41%. This may be
explained by the higher basal resistance of EPCs against
anchorage deprivation than HUVECs. Thus, the beneficial
effect of ILK gene transfer would be more dramatic in
HUVECs than in EPCs.
The results of our tests provide potential insights into the
mechanisms responsible for neovascularization, which re-
quire a process of sequential detachment from ECM and
reattachment onto new ECM. The interaction of ECs with the
ECM inhibits default apoptotic pathways, which become
activated when cell–ECM interactions are disrupted. How-
ever, IL- overexpressing ECs and EPCs were able to over-
come anoikis,27 suspension-induced apoptosis, in vitro. In our
vivo experiment, the dose of native EPCs (2105), delivered
systemically, was subtherapeutic to salvage the ischemic
hindlimb. In contrast, genetic modification with ILK resulted
in a significantly improved outcome even at a dose, which
was only one twentieth (1104) of the control experiment.
Furthermore, the efficacy of systemic delivery of EPCs with
ILK overexpression was comparable to that of local injection
of EPCs. These findings suggest that the efficacy of systemic
administration of EPCs to salvage ischemic limb is signifi-
cantly dependent on the inevitable stresses, such as anchorage
deprivation during systemic administration and nutrient de-
privation in ischemic tissue. Genetic modification with ILK
may be a very effective strategy to overcome such inevitable
stresses during cell therapy for ischemic tissue.
As for which cell signal pathway mediates these changes,
we found that the ILK/Akt/GSK3 axis is activated in ECs
and EPCs. ILK is believed to function as the effecter of
phosphatidylinositol 3-kinase signaling, which positively reg-
ulates protein kinase B/Akt activity and negatively regulates
GSK3 activity.28,29 In addition to regulating the Akt/GSK
axis, ILK mediates the transduction of signals from ECM
components to intracellular protein.30 Therefore, strategies
targeting ILK overexpression may be highly effective in
cell-based therapeutic vasculogenesis in ischemic area.
In conclusion, we showed for the first time that ILK
enhanced survival, reduced apoptosis, and significantly im-
proved function of ECs and EPCs to augment angiogenesis.
This kind of genetic modification to strengthen the EPCs
against the anchorage or nutrient deprivation could improve
the efficacy of therapeutic vasculogenesis by enabling the
systemic administration of the reduced number of cells
required for optimal neovascularization.
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Figure I. ILK expression pattern in in endothelial cells and endothelial progenitor 
cells.  A, Paired immunoblot analysis was used to reconfirmed the endogenous 
expression level of the ILK in HUVECs and EPCs exposed to various stresses.  B, 
Four blots were used for quantification of serial ILK expression pattern between two 
cell types. The expression of ILK greater at baseline in EPCs compared with HUVECs, 
and decreased to a lesser degree after exposure to anchorage-deprivation.  Tubulin was 
used for loading control. * P<0.05, ILK in EPC versus HUVEC. 
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